Medline: Pay

Medline paid its 5 named executives $22.3M in total in FY2025 (Dec). CEO James M. Boyle was paid $3.9M of that.

PayNo stock prices for these years
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

James M. PigottPresident
FY2025 (Dec)
FY2024 (Dec)Not disclosed
2 years
James M. BoyleChief Executive Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
2 years
Michael B. DrazinChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
2 years
Douglas P. GolwasChief Commercial Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
2 years
Stephen L. MillerChief Operating Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
2 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 9 peers with pay on file was $17.1M. The CEO of Medline was paid $3.9M, 77% below the median.

  1. 1Thermo Fisher Scientific
  2. 2Abbott Laboratories
  3. 3Stryker
  4. 43M
  5. 5Becton Dickinson & Co
  6. 6Colgate Palmolive
  7. 7Kimberly Clark
  8. 8Illinois Tool Works
  9. 9Henry Schein
  10. 10Medline
  11. 11Accendra Health, Inc. (f/k/a Owens & Minor, Inc.)Not disclosed
  12. 12Baxter InternationalNot disclosed
  13. 13Danaher CorporationNot disclosed
  14. 14GE HealthCare TechnologiesNot disclosed
  15. 15Honeywell InternationalNot disclosed
  16. 16MedtronicNot disclosed
  17. 17W.W. Grainger, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.